What is Lincomycin Actavis 300mg/ml?
Lincomycin Actavis 300mg/ml is an antibiotic that fights bacteria.
Lincomycin Actavis 300mg/ml is used to treat severe bacterial infections in people who cannot use penicillin antibiotics.
Lincomycin Actavis 300mg/ml is used only for a severe infection. This medicine will not treat a viral infection such as the common cold or flu.
Lincomycin Actavis 300mg/ml may also be used for purposes not listed in this medication guide.
Lincomycin Actavis 300mg/ml indications
Lincomycin Actavis 300mg/ml Sterile Solution is indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of antibiotic-associated pseudomembranous colitis, as described in Warnings, before selecting Lincomycin Actavis 300mg/ml the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin).
Bacteriologic studies should be performed to determine the causative organisms and their susceptibility to Lincomycin Actavis 300mg/ml.
Indicated surgical procedures should be performed in conjunction with antibiotic therapy.
Lincomycin Actavis 300mg/ml has been demonstrated to be effective in the treatment of staphylococcal infections resistant to other antibiotics and susceptible to Lincomycin Actavis 300mg/ml. Staphylococcal strains resistant to Lincomycin Actavis 300mg/ml have been recovered; culture and susceptibility studies should be done in conjunction with therapy with Lincomycin Actavis 300mg/ml. In the case of macrolides, partial but not complete cross-resistance may occur. The drug may be administered concomitantly with other antimicrobial agents when indicated.
Lincomycin Actavis 300mg/ml is not indicated in the treatment of minor bacterial infections or viral infections.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Lincomycin Actavis 300mg/ml and other antibacterial drugs, Lincomycin Actavis 300mg/ml should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
How should I use Lincomycin Actavis 300mg/ml?
Use Lincomycin Actavis 300mg/ml as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- Lincomycin Actavis 300mg/ml is given as an injection at your doctor's office, hospital, or clinic. Contact your health care provider if you have any questions.
- If you miss a dose of Lincomycin Actavis 300mg/ml, call your doctor to find out what to do.
Ask your health care provider any questions you may have about how to use Lincomycin Actavis 300mg/ml.
Uses of Lincomycin Actavis 300mg/ml in details
Lincomycin Actavis 300mg/ml is used in treatment of bacterial infections.
Lincomycin Actavis 300mg/ml description
Each mL of Lincomycin Actavis 300mg/ml Sterile Solution contains Lincomycin hydrochloride equivalent to Lincomycin Actavis 300mg/ml 300 mg.
Lincomycin Actavis 300mg/ml sterile solution contains Lincomycin hydrochloride which is the monohydrated salt of Lincomycin Actavis 300mg/ml, a substance produced by the growth of a member of the lincolnensis group of Streptomyces lincolnensis (Fam. Streptomycetaceae).
The chemical name for Lincomycin Actavis 300mg/ml hydrochloride is Methyl 6, 8-dideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrolidinecarboxamido)-1-thio-D-erythro-α-D-galacto-octopyranoside monohydrochloride monohydrate. Its molecular formula is C18H34N2O6S.HCl. H2O and the molecular weight is 461.01.
Lincomycin Actavis 300mg/ml hydrochloride is a white or practically white, crystalline powder and is odorless or has a faint odor. Its solutions are acid and are dextrorotatory. Lincomycin Actavis 300mg/ml hydrochloride is freely soluble in water; soluble in dimethylformamide and very slightly soluble in acetone.
Excipients/Inactive Ingredients: Benzyl alcohol 9.45 mg added as preservative.
Lincomycin Actavis 300mg/ml dosage
Lincomycin Actavis 300mg/ml Dosage
Generic name: Lincomycin Actavis 300mg/ml HYDROCHLORIDE 300mg in 1mL
Dosage form: injection, solution
The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.
If significant diarrhea occurs during therapy, this antibacterial should be discontinued.
INTRAMUSCULAR
Adults
Serious infections—600 mg (2 mL) intramuscularly every 24 hours. More severe infections—600 mg (2 mL) intramuscularly every 12 hours or more often.
Pediatric patients over 1 month of age
Serious infections—one intramuscular injection of 10 mg/kg (5 mg/lb) every 24 hours. More severe infections—one intramuscular injection of 10 mg/kg (5 mg/lb) every 12 hours or more often.
INTRAVENOUS
Adults
The intravenous dose will be determined by the severity of the infection. For serious infections doses of 600 mg of Lincomycin Actavis 300mg/ml (2 mL of Lincomycin Actavis 300mg/ml) to 1 gram are given every 8 to 12 hours. For more severe infections these doses may have to be increased. In life-threatening situations daily intravenous doses of as much as 8 grams have been given.
Intravenous doses are given on the basis of 1 gram of Lincomycin Actavis 300mg/ml diluted in not less than 100 mL of appropriate solution and infused over a period of not less than one hour.
| Dose | Vol. Diluent | Time |
|---|---|---|
| 600 mg | 100 mL | 1 hr |
| 1 gram | 100 mL | 1 hr |
| 2 grams | 200 mL | 2 hr |
| 3 grams | 300 mL | 3 hr |
| 4 grams | 400 mL | 4 hr |
These doses may be repeated as often as required to the limit of the maximum recommended daily dose of 8 grams of Lincomycin Actavis 300mg/ml.
Pediatric patients over 1 month of age
10 to 20 mg/kg/day (5 to 10 mg/lb/day) depending on the severity of the infection may be infused in divided doses as described above for adults.
NOTE: Severe cardiopulmonary reactions have occurred when this drug has been given at greater than the recommended concentration and rate.
SUBCONJUNCTIVAL INJECTION
0.25 mL (75 mg) injected subconjunctivally will result in ocular fluid levels of antibacterial (lasting for at least 5 hours) with MICs sufficient for most susceptible pathogens.
Patients with diminished renal function
When therapy with Lincomycin Actavis 300mg/ml is required in individuals with severe impairment of renal function, an appropriate dose is 25 to 30% of that recommended for patients with normally functioning kidneys.
More about Lincomycin Actavis 300mg/ml (Lincomycin Actavis 300mg/ml)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- En Espanol
- 1 Review - Add your own review/rating
- Generic Availability
Consumer resources
- Lincomycin Actavis 300mg/ml
- Lincomycin Actavis 300mg/ml (Advanced Reading)
Professional resources
- Lincomycin Actavis 300mg/ml (AHFS Monograph)
- Lincomycin Actavis 300mg/ml (FDA)
Related treatment guides
- Bacterial Infection
- Conjunctivitis, Bacterial
Lincomycin Actavis 300mg/ml interactions
See also:
What other drugs will affect Lincomycin Actavis 300mg/ml?
BCG (Intravesical): Antibiotics may diminish the therapeutic effect of BCG (Intravesical). Avoid combination
BCG Vaccine (Immunization): Antibiotics may diminish the therapeutic effect of BCG Vaccine (Immunization). Monitor therapy
Cholera Vaccine: Antibiotics may diminish the therapeutic effect of Cholera Vaccine. Management: Avoid cholera vaccine in patients receiving systemic antibiotics, and within 14 days following the use of oral or parenteral antibiotics. Avoid combination
Doxofylline: Lincomycin Actavis 300mg/ml may increase the serum concentration of Doxofylline. Monitor therapy
Erythromycin (Systemic): May diminish the therapeutic effect of Lincomycin Actavis 300mg/ml. Avoid combination
Kaolin: May decrease the absorption of Lincosamide Antibiotics. Monitor therapy
Lactobacillus and Estriol: Antibiotics may diminish the therapeutic effect of Lactobacillus and Estriol. Monitor therapy
Mecamylamine: Lincosamide Antibiotics may enhance the neuromuscular-blocking effect of Mecamylamine. Avoid combination
Neuromuscular-Blocking Agents: Lincosamide Antibiotics may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents. Monitor therapy
Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate. Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic. Consider therapy modification
Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected. Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents. Use of this vaccine should be postponed until at least 3 days after cessation of antibacterial agents. Consider therapy modification
Lincomycin Actavis 300mg/ml side effects
See also:
What are the possible side effects of Lincomycin Actavis 300mg/ml?
Applies to Lincomycin Actavis 300mg/ml: capsule, solution
In addition to its needed effects, some unwanted effects may be caused by Lincomycin Actavis 300mg/ml (the active ingredient contained in Lincomycin Actavis 300mg/ml). In the event that any of these side effects do occur, they may require medical attention.
Major Side Effects
You should check with your doctor immediately if any of these side effects occur when taking Lincomycin Actavis 300mg/ml:
More common:
- Abdominal or stomach cramps and pain (severe)
- abdominal tenderness
- diarrhea (watery and severe), which may also be bloody
- fever
- Skin rash, redness, and itching
- sore throat and fever
- unusual bleeding and bruising
Note: Some of the above side effects may also occur up to several weeks after you Stop taking Lincomycin Actavis 300mg/ml.
Minor Side Effects
Some of the side effects that can occur with Lincomycin Actavis 300mg/ml may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:
More common:
- Diarrhea (mild)
- nausea and vomiting
- stomach pain
- Itching of rectal or genital (sex organ) areas
Lincomycin Actavis 300mg/ml contraindications
See also:
What is the most important information I should know about Lincomycin Actavis 300mg/ml?
Before receiving Lincomycin Actavis 300mg/ml, tell your doctor if you have asthma or allergies, a stomach or intestinal disorder such as colitis, liver or kidney disease, or epilepsy or other seizure disorder.
Antibiotic medicines can cause diarrhea, which may be a sign of a new infection. If you have diarrhea that is watery or has blood in it, call your doctor. Do not use any medicine to stop the diarrhea unless your doctor has told you to.
Serious side effects of Lincomycin Actavis 300mg/ml include fever, chills, body aches, flu symptoms, white patches or sores inside your mouth or on your lips, severe blistering or peeling skin rash, feeling like you might pass out, easy bruising or bleeding, unusual weakness, or urinating less than usual or not at all.
Active ingredient matches for Lincomycin Actavis 300mg/ml:
Lincomycin in Bulgaria.
List of Lincomycin Actavis 300mg/ml substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Lincomycin-Suzhou No 6 Pharm (China) | |
| Lincomycine 20% (Netherlands) | |
| Lincomycine 22 Porc Franvet (France) | |
| Lincomycine 8.8 Porc Franvet (France) | |
| Lincomycine Franvet (France) | |
| Lincomycine VMD (Belgium) | |
| Lincomyl 500mg (Australia) | |
| Lincomyn (Brazil) | |
| Linconit | |
| Linconit - INJ / 2ml | $ 0.14 |
| Lincono (Thailand) | |
| Lincono 300 mg/1 mL x 10 mL x 10's (Milano) | |
| Lincopat (Mexico) | |
| Lincophar (Indonesia) | |
| Lincophar 500 mg x 60's (Pharos) | $ 37.24 |
| Lincopharm (Australia) | |
| Lincopharm 800 (Australia) | |
| Lincopi (Vietnam) | |
| Lincopi 600 mg/2 mL x 10 tube 2 mL | |
| Lincoplax (Brazil) | |
| Lincople (Vietnam) | |
| Lincople 600 mg/2 mL x 10 Bottle | |
| Lincoplus (Peru) | |
| Lincorex | |
| Lincosa (Malaysia) | |
| Lincosa 300 mg/1 mL x 10 mL x 1's (ZHPL (Sayona)) | |
| 300 mg x 1ml (ZHPL (Sayona)) | $ 0.11 |
| Lincosa 300mg AMP / 1ml (ZHPL (Sayona)) | $ 0.11 |
| LINCOSA inj 300 mg x 1ml (ZHPL (Sayona)) | $ 0.11 |
| Lincosa 300 mg inj 2 mL x 50 x 1's (ZHPL (Sayona)) | |
| Lincosa 300 mg inj 10 mL x 10 x 1's (ZHPL (Sayona)) | |
| Lincosan (Yemen) | |
| LINCOSCAN 400mg/g dla swin i kurczat For pigs and chickens (Poland) | |
| Lincosol (United States) | |
| Lincostad (Vietnam) | |
| Lincostad 500 mg x 10 Blister x 10 Tablet | |
| Lincotax (Brazil) | |
| Lincotec (Italy) | |
| Lincotic (Pakistan) | |
| Lincotin (Pakistan) | |
| Lincovax (Brazil) | |
| Lincover (Mexico) | |
| LINCOWOCK | |
| LINCOWOCK 1MG INJECTION 1 vial / 1 ML injection each (Wockhardt Ltd) | $ 0.09 |
| LINCOWOCK 2MG INJECTION 1 vial / 2 ML injection each (Wockhardt Ltd) | $ 0.16 |
| Lincowock 2mg Injection (Wockhardt Ltd) | $ 0.08 |
| Lincozaf (Pakistan) | |
| Lincozin (India) | |
| Lincozin 250mg CAP / 10 (Taj Pharma) | $ 0.70 |
| Lincozin 500mg CAP / 10 (Taj Pharma) | $ 1.12 |
| Lincozin 125mg/mL SYR / 60ml (Taj Pharma) | $ 0.55 |
See 520 substitutes for Lincomycin Actavis 300mg/ml | |
References
- PubChem. "lincomycin". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "lincomycin". http://www.drugbank.ca/drugs/DB01627 (accessed September 17, 2018).
- MeSH. "Protein Synthesis Inhibitors". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Lincomycin Actavis 300mg/ml are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Lincomycin Actavis 300mg/ml. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yetConsumer reported age
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
